Can this small-cap healthcare stock continue to beat big-cap rivals?

Roland Head looks at the latest results from a fast-growing healthcare business with strong overseas growth potential.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Investing in small caps has delivered big results for many investors over the last year. Fast-growing smaller firms have lived up to their reputation for outperforming big-cap stocks, but will this situation continue as valuations rise?

Shareholders of infection control specialist Tristel (LSE: TSTL) have seen the value of their shares rise by almost 40% to 159p over the last 12 months. But today’s full-year results from Tristel appear to have left the market unimpressed, despite a 12% rise in revenue. In this article I’ll explain why this might be.

I’ll also contrast Tristel with a larger manufacturer of healthcare products, joint replacement specialist Smith & Nephew (LSE: SN).

Should you invest £1,000 in Smith & Nephew Plc right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Smith & Nephew Plc made the list?

See the 6 stocks

Expenses issues

Sales of Tristel’s infection control products rose by an impressive 12% to £17.1m during the year ending 30 June. Adjusted pre-tax profit rose by 27% to £3.3m, while adjusted earnings rose by 20% to 6.62p per share.

The group’s total dividend — including a 3p per share special payout — rose by 11% to 6.33p per share. Tristel ended the year with net cash of £5.7m, up from £4m at the end of last year.

However, in my view these impressive adjusted figures are clouded by the exclusion of the expenses relating to a £1m stock option bonanza enjoyed by management earlier this year.

This share-based payout is one of the main reasons why Tristel’s weighted average share count rose from 40.7m to 41.9m last year. The dilutive effect of these new shares pushed Tristel’s reported earnings down by 8% to 5.01p per share. This equates to a trailing P/E of 32.

Is Tristel too expensive?

Tristel looks expensive based on historic earnings. However, broker forecasts suggest that adjusted earnings will rise by 15% to 6.8p per share this year, putting the stock on a forecast P/E of 23.

Stock option costs should fall this year, so adjusted earnings will hopefully be closer to the group’s reported numbers. A planned move into the US market in 2018 could give Tristel access to new markets worth up to £18m, according to management estimates.

Although Tristel shares aren’t obviously cheap, I believe they could still deliver further gains. I’d hold for now.

A hip replacement stock?

Shares in joint replacement group Smith & Nephew have risen by 113% during the last five years. But the group’s growth appears to have slowed. Smith & Nephew shares are flat so far this year and don’t look especially cheap, on a 2016 forecast P/E of 18.1. The forecast dividend yield is just 2%, which isn’t very tempting either.

Things could be about to improve, however. Earnings per share are expected to rise by 12% next year, bringing the forecast P/E down to 16. There’s also the potential for a takeover bid. The combination of the weaker pound and Smith & Nephew’s stagnant share price means that for a US buyer, this company would be cheaper than it was at the start of 2016.

It’s worth remembering that despite a £10bn market cap, Smith & Nephew is only a medium-sized player in this sector. A bid could make sense.

Overall, I’d argue that as with Tristel, Smith & Nephew looks fully priced at the moment but has decent medium-term potential.

5 Shares for the Future of Energy

Investors who don’t own energy shares need to see this now.

Because Mark Rogers — The Motley Fool UK’s Director of Investing — sees 2 key reasons why energy is set to soar.

While sanctions slam Russian supplies, nations are also racing to achieve net zero emissions, he says. Mark believes 5 companies in particular are poised for spectacular profits.

Open this new report5 Shares for the Future of Energy — and discover:

  • Britain’s Energy Fort Knox, now controlling 30% of UK energy storage
  • How to potentially get paid by the weather
  • Electric Vehicles’ secret backdoor opportunity
  • One dead simple stock for the new nuclear boom

Click the button below to find out how you can get your hands on the full report now, and as a thank you for your interest, we’ll send you one of the five picks — absolutely free!

Grab your FREE Energy recommendation now

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Number three written on white chat bubble on blue background
Investing Articles

Just released: the 3 best growth-focused stocks to consider buying in April [PREMIUM PICKS]

Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due…

Read more »

Happy young plus size woman sitting at kitchen table and watching tv series on tablet computer
Investing Articles

£10,000 invested in Watches of Switzerland shares 1 year ago is now worth…

Watches of Switzerland shares have been decimated by Trump’s tariffs on Switzerland. Dr James Fox explores whether this is an…

Read more »

Hand flipping wooden cubes for change wording" Panic " to " Calm".
Investing Articles

Growth stocks are crashing! Here’s what I’m doing now

Our writer shares his thoughts as growth stocks get crushed, as well as a favourite from the Nasdaq that he…

Read more »

Investing Articles

What’s going on with the Nvidia share price now?

The Nvidia share price is tanking. Once the most valuable listed company, Nvidia has seen more than $1trn wiped off…

Read more »

Investing Articles

This FTSE AIM stock has £2.3bn in net cash, and a market cap of £2.4bn!

I love this FTSE AIM stock, but it really hasn’t delivered for me yet. The stock trades with crazily low…

Read more »

Smart young brown businesswoman working from home on a laptop
Investing Articles

Down 15% in a week! Are these 5 FTSE 100 fallers screaming buys as markets plunge?

Five of Harvey Jones's favourite FTSE 100 stocks all have the same thing in common – they've fallen around 15%…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

2 stocks that have been crushed and now offer a ton of value

Edward Sheldon has been scanning the market for stocks that offer value after the sell-off. Here are two shares he…

Read more »

Light trails from traffic moving down The Mound in central Edinburgh, Scotland during December
Investing Articles

£10,000 invested in Aston Martin shares at Christmas is now worth…

Aston Martin shares have fallen from above £10 in early 2020 to pennies today. Is this the perfect time for…

Read more »